2006, Volume 13, Issue 02, pages 77-156

Treatment of chronic heart failure (CHF), an important cause of global morbidity and mortality, has evolved in the last three decades.1-3 Activation of neurohormonal systems...

The ASTEROID trial, which showed regression of atherosclerosis by reducing low-density lipoprotein cholesterol to new lows and simultaneously improving high-density lipoprotein cholesterol, was one of...

The second annual survey from the British Junior Cardiologists’ Association (BJCA) has new data on several areas, including the European Working Time Directive, modernising medical...

We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab...and beyond. In this column,...

A constant abundance of food and a sedentary lifestyle has led to an increasing prevalence of obesity in the United Kingdom. This has resulted in...

We summarise recent developments in minimally invasive cardiac surgery. We describe the modifications to anaesthetic technique, incisions, cardiopulmonary bypass and myocardial protection, and the endoscopic...

Low-density lipoprotein cholesterol (LDL-C) reduction alone has consistently achieved a statistically significant 25–30% reduction in clinical events in multiple clinical trials. This degree of clinical...

Referral to cardiac rehabilitation (CR) is often incomplete. Those most likely to benefit are less likely to be offered the service and there has been...

Cardiac catheterisation access site complications are common. Their incidence depends on various risk factors such as female gender, nadir platelet count, diagnostic versus therapeutic intervention,...

The current national target in the UK for total cholesterol is 5 mmol/L. The Primary Care Data Quality (PCDQ) programme reported in 2002 that only...

The British Heart Foundation (BHF) diary has been designed to be a personal record for patients post-myocardial infarction (MI) to record their progress, keep a...